• No results found

AN APPROACH FOR DESIGN AND CHARACTERIZATION OF NIOSOMES FOR CHLORPHENIRAMINE MALEATE

N/A
N/A
Protected

Academic year: 2020

Share "AN APPROACH FOR DESIGN AND CHARACTERIZATION OF NIOSOMES FOR CHLORPHENIRAMINE MALEATE"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig 1: standard calibration curve of Chlorpheniramine maleate
Fig no.2: photographs of niosomes
Table 3:-Entrapment Efficiency of Drug (PDE)
Fig 3: Drug release profile of various niosomes formulations

References

Related documents

Figure 8.31: Cumulative % drug release profile of formulation F7 – F9 Dissolution Profile of Mouth Dissolving Loratadine Tablets (F1 - F9). Figure 8.32: Cumulative % drug

In-vitro release study was carried out and revealed that cumulative % drug release in chewing gum formulations were decreases with increases concentration of gum base. From

Table 1: Tablet composition of different formulations of Bosentan matrix tablets containing controlled release polymers.. Fig 1: Cumulative Percent of Dissolution Date

Niosomal formulations using various surfactants (Span 40, Span 60 and Span 80) were prepared by thin film hydration technique. The best formulation was chosen among

The invitro drug release decreased with increase in the polymer.Analysis of drug release mechanism showed that the drug release from the formulations followed

Formulations were evaluated for weight variation, hardness, friability, drug content, swelling studies, surface pH, bioadhesion strength, invitro drug release,

• The niosomal formulations were evaluated for drug content, entrapment efficiency, in vitro release studies, and kinetic drug release. • The percentage drug content of

The % cumulative drug release (CDR) of all formulations of oral fast dissolving film of domperidone is given in Table 8. Figure 3: % Cumulative drug release of reference formulation